Sosei Articles

BioAlliance Pharma pursues development plan for Loramyc in Japan through partner Sosei

13 March 2013

Sosei assigns SD118 assets to Beijing Tide Pharma

14 August 2012

Novartis COPD drug candidate NVA237 superior to placebo and similar to tiotropium in Ph III

1 July 2011

In Japan, AstraZeneca to co-promote denosumab with Daiichi; Sosei debuts NorLevo

24 May 2011

Japan’s Sosei to acquire Activus Pharma in stock deal

23 June 2010

Sosei and Vectura get $7.5 million milestone each, as Novartis starts Ph III study with QVA149 and NVA237

10 May 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end